Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?

This publication has 24 references indexed in Scilit:

• Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning
  Leukemia, 2004
• Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome
  Blood, 2004
• Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation
  Blood, 2004
• Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients
  Bone Marrow Transplantation, 2004
• A new era of antifungal therapy
  Transplantation and Cellular Therapy, 2004
• Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years
  Blood, 2003
• Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic Cancers
  New England Journal of Medicine, 2001
• Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
  New England Journal of Medicine, 1993
• A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants
  New England Journal of Medicine, 1991
• Bone-Marrow Transplantation
  New England Journal of Medicine, 1975